Rita Nanda to PTEN Phosphohydrolase
This is a "connection" page, showing publications Rita Nanda has written about PTEN Phosphohydrolase.
Connection Strength
0.137
-
Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer. Breast Cancer Res Treat. 2018 02; 167(3):731-740.
Score: 0.137